KNRS Stock Overview
Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases.
Kinarus Therapeutics Holding AG Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CHF0.029|
|52 Week High||CHF0.051|
|52 Week Low||CHF0.024|
|1 Month Change||2.14%|
|3 Month Change||n/a|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-28.50%|
Recent News & Updates
|KNRS||CH Airlines||CH Market|
Return vs Industry: Insufficient data to determine how KNRS performed against the Swiss Airlines industry.
Return vs Market: Insufficient data to determine how KNRS performed against the Swiss Market.
|KNRS Average Weekly Movement||17.2%|
|Airlines Industry Average Movement||6.3%|
|Market Average Movement||4.5%|
|10% most volatile stocks in CH Market||7.8%|
|10% least volatile stocks in CH Market||2.4%|
Stable Share Price: KNRS is more volatile than 90% of Swiss stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: Insufficient data to determine KNRS's volatility change over the past year.
About the Company
Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company is based in Lausanne, Switzerland.
Kinarus Therapeutics Holding AG Fundamentals Summary
|KNRS fundamental statistics|
Is KNRS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|KNRS income statement (TTM)|
|Cost of Revenue||CHF0|
Last Reported Earnings
Next Earnings Date
|Earnings per share (EPS)||0|
|Net Profit Margin||0.00%|
How did KNRS perform over the long term?See historical performance and comparison